Bagwan[17] |
Left atrium (4 × 2 cm) |
Multiple strokes |
Diffuse large B-cell lymphoma |
Not available |
Gelatinous, grape-like, friable |
Not available |
Dimitrova[18] |
Left atrium (7.5 × 4.5 cm) |
Chest pain |
Diffuse large B-cell lymphoma |
Not available |
Partially fimbriated surface, gelatinous and necrotic parts |
Not available |
Loong[11] |
Left atrium (6.5 × 4 cm) |
Cardiogenic shock, ischemic stroke |
Diffuse large B-cell lymphoma |
Type III latency (EBER+, LMP1+) |
Not described |
Patient deceased for chemotherapy complications (neutropenia + pneumonia) at 5 months |
Svec[12] |
Left atrium (3.7 × 1.5 cm) |
Ischemic stroke |
Diffuse large B-cell lymphoma |
Type III latency (EBER +, LMP1+) |
Not described |
No evidence of disease at 7 months |
Bartoloni[13] |
Left atrium (5.5 × 4.5 cm) |
Fever and progressive fatigue |
Atypical lymphoid B-cell proliferation |
Type II latency (EBER +, LMP1+) |
Glistening, villous and gelatinous surface |
No evidence of disease at 72 months |
Tapan[15] |
Left atrium (4.2 × 3.6 cm) |
Palpitations |
Diffuse large B-cell lymphoma |
Type III latency (EBER +, LMP1+) |
Not described |
No evidence of disease at 12 months |
Aguilar[14] |
Left atrium (6 × 2.5 cm) |
Transient ischemic attack |
Diffuse large B-cell lymphoma |
Type III latency (EBER +, LMP1+) |
Not described |
No evidence of disease at 42 months |
Pineda[3] |
Left atrium (6.5 × 3 cm) |
Coronary embolization |
Diffuse large B-cell lymphoma |
Not available |
Reddish, gelatinous |
Not available |
Park[20] |
Left atrium (6 × 3.2 cm) |
Peripheral arterial embolization |
Diffuse large B-cell lymphoma |
Type III latency, EBER + |
Irregular surface, friable |
Not available |
Boyer[9] |
Left atrium (? cm) |
Syncope |
Diffuse large B-cell lymphoma |
EBER+ |
Not available |
No evidence of disease at 130 months |
Boyer[9] |
Left atrium (? cm) |
Syncope, cough, dyspnoea |
Diffuse large B-cell lymphoma |
EBER+, LMP1+ |
Reddish, gelatinous |
Patient died at 2 months for cardiac cause |
Boyer[9] |
Left atrium (? cm) |
Dyspnoea, respiratory failure |
Diffuse large B-cell lymphoma |
EBER+, LMP1+ |
Not available |
Recurrent FA-DLBCL at mitral valve after 25 months. Patient died at 26 months (embolic stroke). |
Yan[10] |
Left atrium (? cm) |
Congestive heart failure |
Diffuse large B-cell lymphoma |
Type III latency, EBER+, LMP1+ |
Myxoid appearance with an abundant fibrinous or mucinous background in the centre |
No evidence of disease at 7 months |
Yan[10] |
Left atrium (? cm) |
Congestive heart failure |
Diffuse large B-cell lymphoma |
Type III latency, EBER+, LMP1+ |
Myxoid appearance with an abundant fibrinous or mucinous background in the centre |
No evidence of disease at 84 months |
Yan[10] |
Left atrium (? cm) |
Congestive heart failure |
Diffuse large B-cell lymphoma |
Type III latency, EBER+, LMP1+ |
Myxoid appearance with an abundant fibrinous or mucinous background in the centre |
No evidence of disease at 3 months |
Yan[10] |
Left atrium (? cm) |
Congestive heart failure |
Diffuse large B-cell lymphoma |
Type III latency, EBER+, LMP1+ |
Myxoid appearance with an abundant fibrinous or mucinous background in the centre |
No evidence of disease at 120 months |
Present case |
Left atrium (3.6 × 3 cm) |
Asthenia, dyspnoea and dizziness |
Diffuse large B-cell lymphoma |
EBER+, LMP1+ |
Gelatinous, grape-like, pale pink, semi-transparent, extremely friable |
No evidence of disease at 4 months |